Sunshine Biopharma Inc. Deferred Tax Assets, Property, Plant and Equipment
Sunshine Biopharma Inc. (SBFM) had Deferred Tax Assets, Property, Plant and Equipment of $2.82 thousand as of 2025-12-31, per its 10-K filed 2026-04-03.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment · last filed 2026-04-03
- 2025-12-31: Deferred Tax Assets, Property, Plant and Equipment $2.82K.
- 2024-12-31: Deferred Tax Assets, Property, Plant and Equipment $0.00.
- 2023-12-31: Deferred Tax Assets, Property, Plant and Equipment $0.00.
- 2022-12-31: Deferred Tax Assets, Property, Plant and Equipment $98.96K.
| Period end | Deferred Tax Assets, Property, Plant and Equipment |
|---|---|
| 2025-12-31 | $2.82K 10-K · filed 2026-04-03 |
| 2024-12-31 | $0.00 10-K · filed 2026-04-03 |
| 2023-12-31 | $0.00 10-K · filed 2025-04-01 |
| 2022-12-31 | $98.96K 10-K · filed 2023-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |